Non-Hodgkin's Lymphoma
Showing NaN - NaN of 28
Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)
Completed
- Non-Hodgkin's Lymphoma
- ibritumomab tiuxetan
- BEAM chemotherapy and autologous stem-cell transplantation
-
Scottsdale, Arizona
- +8 more
Aug 13, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)
Completed
- Non-Hodgkin's Lymphoma
-
Mobile, Alabama
- +120 more
Dec 20, 2019
Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)
Terminated
- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma
- Lenalidomide
- Placebo
-
San Diego, California
- +91 more
Nov 6, 2019
Non-Hodgkin's Lymphoma Trial in Miami, Chicago, Philadelphia (Rituximab, bortezomib)
Completed
- Non-Hodgkin's Lymphoma
-
Miami, Florida
- +3 more
Aug 26, 2019
Non-Hodgkin's Lymphoma, Hodgkins Disease Trial in United States (Fludarabine, Busulfan, Anti-Thymocyte Globulin)
Completed
- Non-Hodgkin's Lymphoma
- Hodgkins Disease
- Fludarabine
- +2 more
-
Chicago, Illinois
- +5 more
Mar 4, 2019
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- bendamustine
- +5 more
-
Tucson, Arizona
- +127 more
Jan 8, 2018
Non-Hodgkin's Lymphoma Trial in United States (AME-133v (LY2469298))
Completed
- Non-Hodgkin's Lymphoma
- AME-133v (LY2469298)
-
Birmingham, Alabama
- +10 more
Jan 5, 2016
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
-
Los Angeles, California
- +19 more
Nov 20, 2015
Non-Hodgkin's Lymphoma Trial in Canada, Puerto Rico, United States (Bendamustine HCl)
Completed
- Non-Hodgkin's Lymphoma
- Bendamustine HCl
-
Birmingham, Alabama
- +39 more
May 8, 2014
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013
Renal Cell Carcinoma, Non-hodgkin's Lymphoma Trial in United States (MDX-1203)
Completed
- Renal Cell Carcinoma
- Non-hodgkin's Lymphoma
- MDX-1203
-
New Haven, Connecticut
- +4 more
May 21, 2013
Non-Hodgkin's Lymphoma Trial in United States (Id-KLH)
Unknown status
- Non-Hodgkin's Lymphoma
- Id-KLH
-
La Jolla, California
- +14 more
Sep 29, 2009
Non-Hodgkin's Lymphoma Trial in United States (Iodine I 131 Tositumomab)
Completed
- Non-Hodgkin's Lymphoma
- Iodine I 131 Tositumomab
-
Bay Pines, Florida
- +5 more
Sep 13, 2007
Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Motexafin gadolinium)
Completed
- Lymphoma
- Non-Hodgkin's Lymphoma
- Motexafin gadolinium
-
San Diego, California
- +6 more
May 11, 2007
Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))
Terminated
- Non-Hodgkin's Lymphoma
- Zevalin (ibritumomab tiuxetan)
- Rituxan (rituximab)
-
Huntsville, Alabama
- +66 more
Sep 8, 2006